Pharmacokinetics (PK)

项目总结/摘要（药代动力学） 药代动力学（PK）共享资源（SR）成立于2009年，由CCSG资助 2012年起加快科技成果转化PK SR的目标是提供高质量、高性价比和高时效的服务， 癌症研究进展它使用密歇根大学综合癌症一对一的咨询 中心（UMCCC）成员在项目开始时，以鼓励创新研究，并支持 多学科合作。SR在能力、服务和人员配置方面已成功发展， 与不断扩大的用户群保持同步。自成立以来，PK SR一直由Duxin Sun博士领导， 在临床前和临床PK和药物开发方面具有丰富经验的熟练研究者。合作 孙博士和他的团队与UMCCC的领导和成员密切合作， UMCCC研究人员通过采用最先进的技术和方法，加速 开发新的抗癌疗法，源于成员的研究。

PROJECT SUMMARY/ABSTRACT (PHARMACOKINETICS) The Pharmacokinetics (PK) Shared Resource (SR) was founded in 2009 and has been funded by the CCSG since 2012. The goal of the PK SR is to provide high quality, cost- and time-efficient services that propel cancer research forward. It uses one-on-one consultations with University of Michigan Comprehensive Cancer Center (UMCCC) members at the start of projects to stimulate innovative research and to support multidisciplinary collaborations. The SR has successfully grown in capability, services, and staffing in order to keep pace with an expanding user base. Since its inception, the PK SR has been led by Duxin Sun, PhD, a skilled investigator with extensive experience in preclinical and clinical PK and drug development. By working closely with UMCCC leaders and members, Dr. Sun and his team have anticipated the changing needs of UMCCC researchers by adopting state-of-the-art technologies and approaches that accelerate the development of novel anticancer therapeutics arising from member research.